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Introduction
First identified in 2005, PARV4 is best characterized in
Western cohorts where it is strongly associated with
other blood borne viruses and occurs only in individuals
with risk factors for parenteral infection (in particular,
injecting drug users). However, studies in Africa have
shown evidence of PARV4 in subjects with no clear risk
factors for acquisition of blood borne viruses. The clini-
cal significance of PARV4 remains uncertain, but there
is growing interest in the role of coinfecting pathogens
in shaping outcomes of HIV, and in chronic viral infec-
tions as determinants of immunological development in
childhood.
Materials and methods
We studied a cohort of HIV-infected mothers (n=32)
and children (n=40; median age 28 months), and HIV-
negative pediatric controls (n=24, median age 86
months) in Kimberley, South Africa. PARV4 serostatus
was determined by ELISA for IgG to the PARV4 VP2
protein. HIV viral load was determined using the Abbott
m2000 assay, and CD4 T cell count by flow cytometry.
Results
In this cohort, 45/96 individuals (46.9%) were positive for
PARV4 IgG, including 19/32 adults (59.4%) and 26/64
children (40.6%). The seroprevalence of PARV4 IgG
increased with age, demonstrating acquisition throughout
childhood, plateauing by age 6-10 years (Fig. 1; R2=0.75 by
logistic regression). There was strong concordance
between maternal and child infection, with the mother’s
PARV4 status being a clear predictor of IgG in her off-
spring (p=0.006). HIV-negative individuals were more
likely than HIV-positive subjects to be PARV4 IgG posi-
tive (p=0.03), although this relationship may be con-
founded by age. There was no relationship between
PARV4 status and HIV viral load or CD4 T cell count in
HIV-infected adults or children.
Conclusions
The epidemiology of PARV4 in this cohort contrasts strik-
ingly with that in Western countries: the prevalence of
PARV4 IgG approached 50%, with evidence for ongoing
transmission throughout the early years of life. The
observed concordance within families is suggestive of
maternal to child transmission. Future studies are planned,
to investigate further the relationship between PARV4 sta-
tus and outcomes of HIV infection.
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